Evidence of mobilization of pluripotent stem cells into peripheral blood of patients with myocardial ischemia

Experimental Hematology

Volumn 38, Issue 12, 2010, Pages

  Abdel Latif, Ahmed ^a   Zuba Surma, Ewa K ^b,c   Ziada, Khaled M ^a   Kucia, Magdalena ^b   Cohen, Donald A ^d   Kaplan, Alan M ^d   Van Zant, Gary ^e   Selim, Samy ^a   Smyth, Susan S ^a   Ratajczak, Mariusz Z ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR NKX2.5; VON WILLEBRAND FACTOR;

AGE; ARTICLE; CELL COUNT; CELL POPULATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; GENE EXPRESSION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEMATOPOIETIC STEM CELL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; STEM CELL MOBILIZATION;

ANGINA;

EID: 78549242967     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.08.003     Document Type: Article

References (45)

1. D'Ippolito G., Diabira S., Howard G., Menei P., Roos B., Schiller P. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 2004, 117:2971-2981.
2. Jiang Y., Jahagirdar B., Reinhardt R., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002, 418:41-49.
3. Kucia M., Halasa M., Wysoczynski M., et al. Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia 2007, 21:297-303.
4. Kucia M., Reca R., Campbell F.R., et al. A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia 2006, 20:857-869.
5. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89:E1-E7.
6. Kucia M., Dawn B., Hunt G., et al. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood following myocardial infarction. Circ Res 2004, 95:1191-1199.
7. Massa M., Rosti V., Ferrario M., et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005, 105:199-206.
8. Shintani S., Murohara T., Ikeda H., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001, 103:2776-2779.
9. Wojakowski W., Tendera M., Kucia M., et al. Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction. J Am Coll Cardiol 2009, 53:1-9.
10. Wojakowski W., Tendera M., Zebzda A., et al. Mobilization of CD34(+), CD117(+), CXCR4(+), c-met(+) stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction. Eur Heart J 2006, 27:283-289.
11. Vandervelde S., van Luyn M.J., Tio R.A., Harmsen M.C. Signaling factors in stem cell-mediated repair of infarcted myocardium. J Mol Cell Cardiol 2005, 39:363-376.
12. de Weger R.A., Verbrugge I., Bruggink A.H., et al. Stem cell-derived cardiomyocytes after bone marrow and heart transplantation. Bone Marrow Transplant 2008, 41:563-569.
13. Deb A., Wang S., Skelding K.A., Miller D., Simper D., Caplice N.M. Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients. Circulation 2003, 107:1247-1249.
14. Quaini F., Urbanek K., Beltrami A.P., et al. Chimerism of the transplanted heart. N Engl J Med 2002, 346:5-15.
15. Rupp S., Koyanagi M., Iwasaki M., et al. Characterization of long-term endogenous cardiac repair in children after heart transplantation. Eur Heart J 2008, 29:1867-1872.
16. Bergmann O., Bhardwaj R.D., Bernard S., et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
17. Fernandez-Aviles F., San Roman J., Garcia-Frade J., et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res 2004, 95:742-748.
18. Kinnaird T., Stabile E., Burnett M., Epstein S. Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences. Circ Res 2004, 95:354-363.
19. Kinnaird T., Stabile E., Burnett M., et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004, 109:1543-1549.
20. Kocher A., Schuster M., Szabolcs M., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001, 7:430-436.
21. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
22. Shake J., Gruber P., Baumgartner W., et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg 2002, 73:1919-1925.
23. Tomita S., Li R., Weisel R., et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999, 100:II247-II256.
24. Yoon Y., Wecker A., Heyd L., et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 2005, 115:326-338.
25. Abdel-Latif A., Bolli R., Tleyjeh I., et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007, 167:989-997.
26. Abdel-Latif A., Bolli R., Zuba-Surma E.K., Tleyjeh I.M., Hornung C.A., Dawn B. Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J 2008, 156:216-226.
27. Zuba-Surma E.K., Kucia M., Dawn B., Guo Y., Ratajczak M.Z., Bolli R. Bone marrow-derived pluripotent very small embryonic-like stem cells (VSELs) are mobilized after acute myocardial infarction. J Mol Cell Cardiol 2008, 44:865-873.
28. Zuba-Surma E.K., Kucia M., Abdel-Latif A., et al. Morphological characterization of very small embryonic-like stem cells (VSELs) by ImageStream system analysis. J Cell Mol Med 2008, 12:292-303.
29. Fukuhara S., Tomita S., Nakatani T., Yutani C., Kitamura S. Endogenous bone-marrow-derived stem cells contribute only a small proportion of regenerated myocardium in the acute infarction model. J Heart Lung Transplant 2005, 24:67-72.
30. Tendera M., Wojakowski W., Ruzyllo W., et al. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J 2009, 30:1313-1321.
31. Wojakowski W., Tendera M., Kucia M., et al. Cardiomyocyte differentiation of bone marrow-derived Oct-4+CXCR4+SSEA-1+ very small embryonic-like stem cells. Int J Oncol 2010, 37:237-247.
32. Dawn B., Tiwari S., Kucia M.J., et al. Transplantation of bone marrow-derived very small embryonic-like stem cells attenuates left ventricular dysfunction and remodeling after myocardial infarction. Stem Cells 2008, 26:1646-1655.
33. Ratajczak M., Zuba-Surma E., Wysoczynski M., Wan W., Ratajczak J., Kucia M. Hunt for pluripotent stem cell e Regenerative medicine search for almighty cell. J Autoimmun 2008, 30:151-162.
34. Seta N., Kuwana M. Human circulating monocytes as multipotential progenitors. Keio J Med 2007, 56:41-47.
35. Deans R., Moseley A. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000, 28:875-884.
36. Zangrossi S., Marabese M., Broggini M., et al. Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. Stem Cells 2007, 25:1675-1680.
37. Zuba-Surma E., Kucia M., Izabela Klich I., et al. Optimization of isolation and further molecular and functional characterization of SSEA-4+/Oct-4+/CD133+/CXCR4+/LINneg/CD45neg Very Small Embryonic-Like (VSEL) stem cells isolated from umbilical cord blood. Blood 2008, 112:807.
38. Kucia M., Dawn B., Hunt G., et al. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res 2004, 95:1191-1199.
39. Wojakowski W., Tendera M., Michałowska A., et al. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004, 110:3213-3220.
40. Kucia M., Ratajczak J., Ratajczak M.Z. Bone marrow as a source of circulating CXCR4+ tissue-committed stem cells. Biol Cell 2005, 97:133-146.
41. Losordo D.W., Schatz R.A., White C.J., et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 2007, 115:3165-3172.
42. Pasquet S., Sovalat H., Henon P., et al. Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct. Cytotherapy 2009, 11:1002-1015.
43. Xu R.X., Chen X., Chen J.H., Han Y., Han B.M. Mesenchymal stem cells promote cardiomyocyte hypertrophy in vitro through hypoxia-induced paracrine mechanisms. Clin Exp Pharmacol Physiol 2009, 36:176-180.
44. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
45. Peichev M., Naiyer A.J., Pereira D., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000, 95:952-958.